← All trials
NCT06690450
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2001
- Primary completion
- Jan 31, 2002
- Completion date
- Feb 28, 2002
- First posted
- Nov 15, 2024
- Last posted
- Nov 15, 2024
- Enrollment
- 400
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- American Regent, Inc.Lead sponsor
- InnovadermOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.